A business in context

SXTC research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 6-K · Current report

    Report date 2026-10-21 · 0001213900-26-111404

  2. 6-K · Current report

    Report date 2026-10-09 · 0001213900-26-108557

  3. 6-K · Current report

    Report date 2026-10-08 · 0001213900-26-107829

  4. 6-K · Current report

    Report date 2026-10-08 · 0001213900-26-107719

  5. 6-K · Current report

    Report date 2026-08-28 · 0001213900-26-095147

  6. 6-K · Current report

    Report date 2026-07-24 · 0001213900-26-081405

  7. 6-K · Current report

    Report date 2026-07-06 · 0001213900-26-075528

  8. 20-F · Annual report

    Report date 2026-03-31 · 0001213900-26-074310

  9. 6-K · Current report

    Report date 2026-06-01 · 0001213900-26-063591

  10. 6-K · Current report

    Report date 2026-05-04 · 0001213900-26-051679

  11. 6-K · Current report

    Report date 2026-04-09 · 0001213900-26-041765

  12. 6-K · Current report

    Report date 2026-01-13 · 0001213900-26-003910

  13. 6-K · Current report

    Report date 2025-09-30 · 0001213900-25-127097

  14. 20-F · Annual report

    Report date 2025-03-31 · 0001213900-25-069688

  15. 6-K · Current report

    Report date 2025-07-29 · 0001213900-25-068429

  16. 6-K · Current report

    Report date 2025-07-15 · 0001213900-25-064149

  17. 6-K · Current report

    Report date 2025-06-16 · 0001213900-25-054611

  18. 6-K · Current report

    Report date 2025-05-13 · 0001213900-25-042394

  19. 6-K · Current report

    Report date 2024-09-30 · 0001013762-25-003583

  20. 6-K · Current report

    Report date 2025-03-19 · 0001213900-25-024830

  21. 6-K · Current report

    Report date 2025-01-27 · 0001213900-25-006976

  22. 6-K · Current report

    Report date 2025-01-23 · 0001213900-25-005977

  23. SC 13G/A · Ownership disclosure

    0001851416-24-000007

  24. 6-K · Current report

    Report date 2024-10-15 · 0001213900-24-087794

  25. SC 13G/A · Ownership disclosure

    0001104659-24-089946

  26. 20-F · Annual report

    Report date 2024-03-31 · 0001213900-24-068266

  27. SC 13G/A · Ownership disclosure

    0001104659-24-066985

  28. 6-K · Current report

    Report date 2024-05-14 · 0001213900-24-042947

  29. 6-K · Current report

    Report date 2023-09-30 · 0001213900-24-030634

  30. SC 13G/A · Ownership disclosure

    0001104659-24-012689

  31. SC 13G · Ownership disclosure

    0001104659-24-012558

  32. 20-F · Annual report

    Report date 2023-03-31 · 0001213900-23-061294

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001723980China SXT Pharmaceuticals, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2025-03-31$1.74M$1.86M
    2024-03-31$1.93M$2.12M
    2023-03-31$1.97M$2.24M
    2022-03-31$2.60M$3.17M
    2021-03-31$4.78M$6.19M
    2020-03-31$5.16M$6.77M
    2019-03-31$7.01M$9.37M
    2018-03-31$7.02M$9.60M

    Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

    Explore the CPI history ↗